Awakn Enters Global Licensing Agreement for Proprietary Sublingual S-Ketamine Formulation With LTS

Awakn announces it has signed a global licensing agreement with LTS Lohmann Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company. The agreement is for a proprietary S-ketamine...